Special thanks to our Platinum Sponsor Morgan Stanley
Registered attendees will receive an email with the subject line “Welcome to the State of Possible Conference 2020 - Event Access Link” from registrations@bizzabo.com.
The State of Possible Conference, MassBio's Annual Meeting, will now be hosted virtually on August 26-27, 2020. Featuring interactive networking and a groundbreaking viewer experience, this event will not be your average webinar.
We will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees will hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks®, inspiring and engaging content in the style of a TED Talk.
To inquire about sponsorship opportunities, contact Laura Rudberg.
2020 State of Possible Conference Refund Policy
NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.
Session Title | Start Time | End Time |
---|---|---|
Resilience, Grit, Freedom to Fail and Pivot
Biotech is not for the risk averse. Most successful entrepreneurs and investors have experienced multiple failures on their way to commercialization, and many have had to scrap what they were working on and start over. Beyond the statistics of scientific and clinical results missing desired endpoints, hear the personal stories of those who have lived the ups and downs of the long journey from intriguing science to patient bedside. |
8/26/2020 11:30 AM | 8/26/2020 12:00 PM |
From Seed to Series A: Creative Ways to Fund Your Startup
The platform-based, venture-created, $100M+ Series A startup is now a fixture in Massachusetts biotech. However, most first-time founders come straight from academia and struggle to secure funding to demonstrate meaningful in-vivo efficacy of their product candidate. Since therapeutics' risk, time and scale of capital doesn't match the needs of angel investors, who will fund the next generation of great ideas and leaders? This panel will explore alternate forms of funding along with the critical role of mentors, advisory boards, and other support systems in navigating this landscape. |
8/26/2020 1:00 PM | 8/26/2020 1:30 PM |
Supporting Regional Growth of the Life Sciences Beyond Cambridge
One of the greatest strengths of Kendall Square is the sheer density of biopharmas, research institutions, academic institutions, and proximity to the best academic medical centers in the world. Yet, the success of this mini cluster within Massachusetts is also its greatest weakness. Companies struggle to afford the real estate and employees are increasingly frustrated with their commutes and housing costs – leading more companies to move outside of Cambridge. This panel will address why this is a good thing, how to support the continued growth of the industry across Massachusetts, and what kinds of infrastructure investments must be made to ensure success. |
8/27/2020 10:15 AM | 8/27/2020 10:45 AM |